|
1
|
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
|
JAMA
|
2005
|
3.99
|
|
2
|
Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study.
|
Gastroenterology
|
2008
|
1.69
|
|
3
|
Native Hawaiians mortality, morbidity, and lifestyle: comparing data from 1982, 1990, and 2000.
|
Pac Health Dialog
|
2004
|
1.61
|
|
4
|
International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.51
|
|
5
|
Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.17
|
|
6
|
Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies.
|
Cancer Res
|
2006
|
1.16
|
|
7
|
Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center.
|
Clin Cancer Res
|
2010
|
1.05
|
|
8
|
Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer.
|
Gut
|
2012
|
0.99
|
|
9
|
Haplotypes of the estrogen receptor beta gene and breast cancer risk.
|
Int J Cancer
|
2008
|
0.99
|
|
10
|
Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium.
|
Carcinogenesis
|
2011
|
0.99
|
|
11
|
A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
|
Breast Cancer Res
|
2006
|
0.97
|
|
12
|
Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.92
|
|
13
|
Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything?
|
Fam Cancer
|
2013
|
0.83
|
|
14
|
Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry.
|
World J Gastroenterol
|
2013
|
0.80
|